Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ketamine in the Treatment of Suicidal Depression

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by New York State Psychiatric Institute
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
New York State Psychiatric Institute
ClinicalTrials.gov Identifier:
NCT01700829
First received: October 2, 2012
Last updated: September 6, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)